(1) 河南省自然科学基金, 基于菁染料NIR-II光热免疫偶联物的分子调控及抗肺癌性能研究，2024-02至2026-02，5万元，在研，主持

(2) 河南省高等学校重点科研项目, 电子效应介导近红外二区光热免疫诊疗剂的抗肿瘤性能研究, 2024-01至2026-01，3万元，在研，主持

(3) 河南大学青年交叉基金，NIR-II菁染料类光热免疫偶联物分子调控及其抗肿瘤性能研究，2023-07至2026-07，20万元，在研，主持

[1] Xiaojing Li, Wen Sun*, Jiangli Fan*, Xiaojun Peng, et al. An organic nanotherapeutic agent self-assembled from cyanine and Cu (II) for combined photothermal and chemodynamic therapy [J]. Advanced Healthcare Materials, 2021, 2101008.

[2] Xiaojing Li, Wen Sun*, Jiangli Fan*, Xiaojun Peng, et al. H-aggregates of prodrug-hemicyanine conjugate for enhanced photothermal therapy and sequential hypoxia-activated chemotherapy [J]. ACS Materials Letters, 2022, 4(4): 724-732.

[3] Xiaojing Li, Wen Sun*, Jiangli Fan*, Xiaojun Peng, et al. Red light-triggered polyethylene glycol deshielding from photolabile cyanine-modified mesoporous silica nanoparticles for on-demand drug release [J]. ACS Applied Bio Materials, 2020, 3: 8084-8093.

[4] Xiaojing Li, Wen Sun*, Jiangli Fan*, Xiaojun Peng, et al. Light-triggered dePEGylation with decreasing the diameter of hydroxyapatite nanocarriers for enhanced cellular uptake and tumor penetration [J]. Nano select, 2021, 1-8.

[5] Xiaojing Li, Jiangli Fan*, Xiaojun Peng, et al. PEG 化羟基磷灰石纳米体系的制备及双通道荧光成像 [J]. 化工学报, 2020, 71: 4808-4819.